BiotechTube
Home/Biomosaics/Mark Allegretta, PhD
MA

Mark Allegretta, PhD

Co-founder, Director

Biomosaics

Therapeutic Areas

Oncology

Biomosaics Pipeline

DrugIndicationPhase
CanAg® Glypican-3 EIADetection of soluble GPC3 in serum/plasmaCommercial
Glypican-3 Antibodies for IHCDetection of GPC3 in tissue samplesCommercial
Glypican-3 Immunohistochemistry KitsDetection of GPC3 in tissue samplesCommercial

Leadership Team at Biomosaics

RD
Ronald D. Guttmann, MD, FRCPC
Director
TS
Thomas S. Gillespie, B.C.L.
Director
View full Biomosaics profile